Excepgen

Developer of protein production technologies

placeSan Francisco, California, United States calendar_todayFounded 2017 groups1 employees language excepgen.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 61 times.

YearFilings
20211
20223
20234
20243
20254

Investor mix

6 investors on record; lead investors include Y Combinator, RA Capital Management.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon